Positive End Expiratory Pressure With A T-piece Resuscitator For Near-Term and Term Infants With Respiratory Distress
1 other identifier
interventional
64
0 countries
N/A
Brief Summary
Evaluating the effect of early application of Continuous positive airway pressure (CPAP) via Neopuff in cases of transient tachypnea of the newborn(TTN) and its role in decreasing the duration and complication of TTN.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Nov 2011
Shorter than P25 for phase_2
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2013
CompletedFirst Submitted
Initial submission to the registry
May 16, 2013
CompletedFirst Posted
Study publicly available on registry
May 22, 2013
CompletedMay 22, 2013
May 1, 2013
1.2 years
May 16, 2013
May 20, 2013
Conditions
Outcome Measures
Primary Outcomes (1)
Need for admissions to NICU secondary to TTN
24 hours
Secondary Outcomes (7)
Levels of plasma brain natriuretic peptide and clinical outcome [Time Frame: 24 hours].
24 hours
Duration of tachypnea.
until discharge
Duration and type of oxygen therapy.
ntil discharge
Antibiotic treatment.
until discharge
Incidence of pulmonary air leaks
ntil discharge
- +2 more secondary outcomes
Study Arms (2)
Neopuff group
EXPERIMENTALincludes 34 newborns showing signs of TTN who received CPAP (5 cm of H2O) via T- piece (Neopuff; Fisher and Paykel Healthcare, Auckland, New Zealand).
Control group
NO INTERVENTIONincludes 30 newborns who will receive nasal prong oxygen treatment; standard care according to Siva Subramanian et al. (2010).
Interventions
* Group I neonates (Experimental group) includes 30 newborns showing signs of TTN who will receive administration of CPAP (5 cm of H2O) via T- piece (Neopuff; Fisher and Paykel Healthcare, Auckland, New Zealand). * Group II neonates (Control group) includes 30 newborns who will receive nasal prong oxygen treatment; standard care according to Siva Subramanian et al. (2010).
Eligibility Criteria
You may qualify if:
- Near term infants (36-37 weeks gestational age) and Full term infants (38-41 weeks gestational age).
- Presence of signs of respiratory distress (Tachypnea, intercostal and subcostal retractions, nasal flaring and grunting) evident shortly after birth.
- Cesarean section (CS) was defined as elective when surgery was performed before the onset of labor, with all other cases defined as secondary CS.
You may not qualify if:
- Presence of any of the risk factors for neonatal sepsis such as Prolonged Rupture of Membranes for ≥48 hours (PROM), maternal fever, maternal chorioamnionitis or positive maternal GBS colonization.
- Presence of any other cause of respiratory distress, eg.
- congenital malformations affecting the cardiorespiratory system ,
- chromosomal aberrations,
- depression at birth (Apgar score at 5 minutes of \< 7 or umbilical artery pH of \< 7.10),
- fetal hydrops,
- persistent pulmonary hypertension,
- and meconium aspiration syndrome.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rania A. El-Farrash, MD, PhD
Associate Professor of Pediatrics, Department of Pediatrics, Ain Shams University, Cairo, Egypt
- STUDY CHAIR
Amani O. Mahmoud, MD
Professor of Pediatrics, Department of Pediatrics, Ain Shams University, Cairo, Egypt
- PRINCIPAL INVESTIGATOR
Enas H. Abdul-Hady, M.B.B.Ch
Ministry of Health
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of Pediatrics
Study Record Dates
First Submitted
May 16, 2013
First Posted
May 22, 2013
Study Start
November 1, 2011
Primary Completion
January 1, 2013
Study Completion
May 1, 2013
Last Updated
May 22, 2013
Record last verified: 2013-05